This One Dietary Condition Fueled Cancer Cells — And It’s Not Sugar

Medical students gathered around a laptop in a classroom — Photo: ARLOU_ANDREI / Shutterstock

A new lab study found that fat, not sugar, pushed breast cancer cells to spread the fastest.

Quick Take

Princeton engineers built a lab model of triple-negative breast cancer and tested it against high-fat, high-glucose, high-insulin, and high-ketone conditions.
High-fat conditions caused the most invasion into surrounding tissue, even though tumor growth rates stayed similar across all groups.
Researchers linked the effect to a molecule called MMP1, which breaks down the tissue structure that normally contains tumor cells.
The finding builds on years of animal and lab studies tying high-fat diets to worse outcomes in glioblastoma, prostate, and esophageal cancers.

What the Princeton Study Found

Engineers at Princeton built a 3D microfluidic model of triple-negative breast cancer, a hard-to-treat cancer type. They exposed tumor cells to four separate conditions: high fat, high glucose, high insulin, and high ketones. Only the high-fat environment pushed cancer cells to invade nearby tissue at the highest rate the team observed.

The tumors grew at roughly the same speed no matter which condition they sat in. But the high-fat tumors looked different under the microscope. Their structure broke apart. Cells drifted away from the tumor core and pushed out toward the edges, a hallmark of cancer preparing to spread.

The Molecule Behind the Spread

Researchers traced this behavior to MMP1, an enzyme that chews through the structural scaffolding surrounding cells. High-fat conditions raised MMP1 activity, giving tumor cells a tool to break free of their normal boundaries. That mechanism offers a plausible explanation for why fat, specifically, changed tumor shape and movement when sugar and insulin did not produce the same effect in this model.

Older Research Already Pointed This Way

This is not the first time fat has been linked to more aggressive cancer behavior. A 2009 mouse study found a 300 percent jump in metastasis among animals fed a high-fat diet compared to those on a lean diet. A separate glioblastoma study at Cleveland Clinic found that mice on high-fat diets developed more aggressive tumors and had shorter survival times.

Prostate cancer research out of Weill Cornell Medicine found a similar pattern in both mice and actual patients. Researchers reported that men eating high-fat diets were more likely to die of their cancer than men eating low-fat diets, and tied the effect to metabolic and epigenetic changes that helped cancer cells grow. A 2015 study on esophageal adenocarcinoma found the same direction of effect, with tumors in high-fat-diet mice growing faster and showing higher metabolic activity.

Fat and Cancer Research Sits in a Bigger, Mixed Picture

Not every study on dietary fat and cancer points the same direction. Large reviews of human data have found mixed results depending on the cancer type and the kind of fat studied. Colorectal cancer reviews have found no significant link to total fat intake, while skin cancer research found some fat types actually lowered risk for certain tumor types. Breast cancer reviews, by contrast, have more often found a link between higher fat intake and worse outcomes.

That mixed record does not cancel out the Princeton findings. It puts them in context. Lab models like the one used at Princeton let scientists isolate exactly what a fat-rich environment does to tumor cells, cell by cell, without the thousand other variables present in a real human diet. Human nutrition studies capture messier real-world eating patterns, which is why results across cancer types can differ so much from one study to the next.

Why This Study Deserves Attention Now

Triple-negative breast cancer is one of the deadliest breast cancer subtypes precisely because it spreads aggressively and resists many standard treatments. Finding a dietary condition that speeds up that exact invasive behavior in a controlled lab setting gives researchers a specific target, MMP1, to study further. This lab result is not a clinical trial result showing that cutting fat will stop a real tumor from spreading in a patient.

What it does show, clearly, is a mechanism worth taking seriously. Combined with the prostate, glioblastoma, and esophageal findings before it, the Princeton work adds another data point to a growing body of evidence that fat-rich environments can change how cancer cells behave, not just how fast they grow. For patients and families weighing dietary choices during cancer treatment, that distinction between growth and invasion matters a great deal.